AwardTape · Defense awards · Eitr Biologics, Inc
Eitr Biologics, Inc: $5.0M in DoD and DHS awards
Eitr Biologics, Inc holds 9 DoD and DHS prime awards with $5.0M obligated Nov 16, 2023 to May 21, 2026. Largest category: Science and technology R&D at $4.0M; largest buyer: Defense Health Agency at $5.0M.
| Obligated FY2024+ | $5.0M |
|---|---|
| Awards | 9 |
| FY2024 | $2.5M |
| FY2025 | $1.2M |
| FY2026 to date | $1.3M |
| Lifetime obligated on these awards | $5.8M |
| Parent company (as reported) | Eitr Biologics, Inc |
| First and latest action | Nov 16, 2023 · May 21, 2026 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Science and technology R&D | $4.0M | 7 awards | 80% |
| 2 | Health care services | $1.0M | 2 awards | 20% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Defense Health Agency | $5.0M | 9 awards | 100% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| HT942524F0269 delivery order | $1.9M | Novel nanotherapeutics | Defense Health Agency | Science and technology R&D | Jul 2, 2025 DoD 90d |
| HT942526FE010 delivery order | $927K | Novel bispecific broad spectrum nanobody | Defense Health Agency | Science and technology R&D | Jan 28, 2026 DoD 90d |
| HT942524P0015 purchase order | $730K | Sorting peripheral blood mononuclear cells from lassa fever virus survivors to discover and produce monoclonal antibodies for assessment in in vitro and in vivo assays | Defense Health Agency | Health care services | May 12, 2025 DoD 90d |
| HT942524F0127 delivery order | $500K | Develop a novel odin therapeutic medical countermeasure capable of protecting against pneumonic unencapsulated y. pestis. | Defense Health Agency | Science and technology R&D | May 16, 2024 DoD 90d |
| HT942525F0221 delivery order | $300K | Novel nanotherapeutics | Defense Health Agency | Science and technology R&D | May 19, 2025 DoD 90d |
| HT942523P0004 purchase order | $277K | Novel cell sorting | Defense Health Agency | Health care services | Aug 28, 2024 DoD 90d |
| HT942626FE033 delivery order | $270K | Novel bispecific broad spectrum nanobody | Defense Health Agency | Science and technology R&D | Mar 30, 2026 DoD 90d |
| HT942626FE055 delivery order | $100K | Novel bispecific broad spectrum nanobody | Defense Health Agency | Science and technology R&D | May 21, 2026 DoD 90d |
| HT942523D0011 IDIQ contract | $0 | Novel nanotherapeutics for combatting pneumonic plague | Defense Health Agency | Science and technology R&D | Mar 9, 2026 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial